#Durasert - Twitter Hashtag

about 3 years ago

That’s a wrap! $EYPT had a great presence at the @asrsdocs Annual Meeting presenting the results of our Phase 1 #DAVIO trial, #DAVIO2 updates & #PK data on our #Durasert delivery technology. #OphthoTwitter

EyePointPharma's tweet photo. That’s a wrap! $EYPT had a great presence at the @asrsdocs Annual Meeting presenting the results of our Phase 1 #DAVIO trial, #DAVIO2 updates & #PK data on our #Durasert delivery technology. #OphthoTwitter https://t.co/WowZhNpxb8

0

2

0

168

EyePoint

@EyePointPharma

about 3 years ago

$EYPT is presenting #PK data on our #Durasert delivery technology as well as data from our Phase 1 #DAVIOTrial in wet AMD at this week’s @asrsdocs Annual Meeting! We look forward to discussing our retina pipeline with leaders from across the country. See you there! #ASRS

EyePointPharma's tweet photo. $EYPT is presenting #PK data on our #Durasert delivery technology as well as data from our Phase 1 #DAVIOTrial in wet AMD at this week’s @asrsdocs Annual Meeting! We look forward to discussing our retina pipeline with leaders from across the country. See you there! #ASRS https://t.co/d21QjBiwnp

0

3

1

0

278

Eyewire+ @eyewireplus

over 3 years ago

.@EyePointPharma & Rallybio announced a research collaboration aimed at evaluating sustained delivery of Rallybio’s inhibitor of complement component 5 using EyePoint’s proprietary #Durasert technology for sustained #intraocular drug delivery. https://t.co/yCQoqoJbz7

eyewireplus's tweet photo. .@EyePointPharma & Rallybio announced a research collaboration aimed at evaluating sustained delivery of Rallybio’s inhibitor of complement component 5 using EyePoint’s proprietary #Durasert technology for sustained #intraocular drug delivery. https://t.co/yCQoqoJbz7 https://t.co/aTJcuycVJl

0

3

1

0

343

EyePoint

@EyePointPharma

over 3 years ago

#NEWS: $EYPT & RallyBio announce research collaboration to evaluate Rallybio’s inhibitor of complement C5 and EyePoint’s proprietary #Durasert technology for sustained intraocular delivery in #dryAMD & #GeographicAtrophy. Learn more: https://t.co/QpozOb2KgD

EyePointPharma's tweet photo. #NEWS: $EYPT & RallyBio announce research collaboration to evaluate Rallybio’s inhibitor of complement C5 and EyePoint’s proprietary #Durasert technology for sustained intraocular delivery in #dryAMD & #GeographicAtrophy.

Learn more: https://t.co/QpozOb2KgD https://t.co/A52lZCblgk

0

2

0

586

EyePoint

@EyePointPharma

almost 6 years ago

We had a great #wetAMD roundtable event last week where CEO Nancy Lurker spoke about the company’s #Durasert technology and how it helps deliver sustained therapeutics to the eye. Click here to learn more: https://t.co/1v8A5O2ckz